Vertero Completes Enrollment in Phase 1b VT-5006 Study
Vertero completed patient enrollment in its Phase 1b clinical study of VT-5006, an investigational treatment for Parkinson’s disease.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.